RESEARCH CONTEXT:All peptide information is for educational purposes only. Not medical advice. Peptides are research chemicals not approved for human use. Full disclosure →

← Peptides A–Z/MetabolicResearch: Established

Tesamorelin

Stabilized GHRH analogue with FDA approval for HIV-associated lipodystrophy; studied for visceral adiposity.

Overview

Full research content for the Overview section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

Mechanism of Action

Primary Mechanism

GHRH analogue that increases GH/IGF-1 axis, reduces visceral fat accumulation.

Full research content for the Mechanism of Action section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

Research Summary

Full research content for the Research Summary section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

Dosing Protocols

Research Context Only

Dosing information below is derived exclusively from published research and is provided in an academic context. This is not medical advice.

Full research content for the Dosing Protocols section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

Sources & Vendors

Affiliate Disclosure

Vendor links below may be affiliate links. We earn a commission at no cost to you, which funds independent third-party testing.

Full research content for the Sources & Vendors section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

References

Full research content for the References section of Tesamorelin is being compiled by the Peptide Report editorial team from peer-reviewed sources. Content will include citations from PubMed, clinical trial registries, and published research papers.

[1]Peer-reviewed citation — PubMed reference for Tesamorelin research to be added.
[2]Peer-reviewed citation — PubMed reference for Tesamorelin research to be added.
[3]Peer-reviewed citation — PubMed reference for Tesamorelin research to be added.